Evidence map›Paper›PMID 42181664›Full record

ArticleOphthalmology science2026

Predicting Visual Field Loss in Glaucoma Using OCT and Deep Learning: A Comparative Study of U-Net Variants.

Kyoung Ohn, Jiwook Hwang, Jiwon Jung, Woong-Joo Whang

Abstract read
In one paragraph

Article in Ophthalmology science, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Kyoung OhnDepartment of Ophthalmology, Yeouido St. Mary's Eye Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea.
Jiwook HwangPuzzleAI Co., Ltd., Seoul, Republic of Korea.
Jiwon JungPuzzleAI Co., Ltd., Seoul, Republic of Korea.
Woong-Joo WhangDepartment of Ophthalmology, Yeouido St. Mary's Eye Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Purpose: Glaucoma is a chronic eye disease that progressively damages the optic nerve, leading to irreversible visual field (VF) loss. OCT and VF tests are essential for monitoring structural and functional changes in glaucoma. This study applies 3 deep learning models-R2 U-Net, Dense U-Net, and Nested U-Net (UNet++)-to predict VF outcomes using retinal nerve fiber layer (RNFL) thickness maps from OCT images. Design: A retrospective cross-sectional study. Subjects: A total of 1640 patients with glaucoma diagnosed at a tertiary referral center were included. Only 1 eye (left eye) per patient was analyzed to avoid intereye correlation. Eyes included patients with early, moderate, and advanced glaucoma. Methods: We used a dataset of OCT and VF data from 1640 glaucoma patients, divided into training, validation, and test sets. The 3 deep learning models were trained and evaluated using 5 performance metrics: mean squared error (MSE), mean absolute error (MAE), peak signal-to-noise ratio (PSNR), structural similarity index (SSIM), and Fréchet inception distance (FID). The goal was to predict VF outcomes based on OCT-derived RNFL thickness maps. Main Outcome Measures: Accuracy and image quality of predicted VF maps compared with ground truth VF maps, assessed by MSE, MAE, PSNR, SSIM, and FID. Results: R2 U-Net outperformed all other architectures, with the lowest MSE and MAE values and the highest SSIM and PSNR scores, indicating superior accuracy and image quality. Nested U-Net and Dense U-Net lagged, with Dense U-Net showing the lowest predictive accuracy. Conclusions: This study is the first to apply generative artificial intelligence (AI) models, such as R2 U-Net, to predict VF loss based on OCT data, with both models demonstrating exceptional performance. These findings highlight the potential of generative AI to enhance glaucoma diagnosis and facilitate personalized treatment planning. Financial Disclosures: The authors have no proprietary or commercial interest in any materials discussed in this article.

Indexed as

Deep learningGenerative modelsGlaucomaOCTVisual field prediction

Identifiers

PMID42181664
PMCPMC13195606

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.